Return On Assets of Eiger BioPharmaceuticals, Inc. from 30 Sep 2014 to 31 Dec 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eiger BioPharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2014 to 31 Dec 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Assets for the quarter ending 31 Dec 2023 was -113%, a 69% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2023 was -113%, a 69% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2022 was -67%, a 194% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2021 was -23%, a 59% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2023 -113% -46% -69% 01 Oct 2023 31 Dec 2023
Q3 2023 -100% -36% -57% 01 Jul 2023 30 Sep 2023
Q2 2023 -88% -27% -45% 01 Apr 2023 30 Jun 2023
Q1 2023 -74% -14% -24% 01 Jan 2023 31 Mar 2023
Q4 2022 -67% -44% -194% 01 Oct 2022 31 Dec 2022
Q3 2022 -64% -44% -217% 01 Jul 2022 30 Sep 2022
Q2 2022 -61% -45% -283% 01 Apr 2022 30 Jun 2022
Q1 2022 -60% -45% -307% 01 Jan 2022 31 Mar 2022
Q4 2021 -23% +32% +59% 01 Oct 2021 31 Dec 2021
Q3 2021 -20% +38% +65% 01 Jul 2021 30 Sep 2021
Q2 2021 -16% +48% +75% 01 Apr 2021 30 Jun 2021
Q1 2021 -15% +47% +76% 01 Jan 2021 31 Mar 2021
Q4 2020 -55% +7.6% +12% 01 Oct 2020 31 Dec 2020
Q3 2020 -58% +4.5% +7.3% 01 Jul 2020 30 Sep 2020
Q2 2020 -63% +5.6% +8.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -61% +11% +15% 01 Jan 2020 31 Mar 2020
Q4 2019 -62% +13% +17% 01 Oct 2019 31 Dec 2019
Q3 2019 -62% +23% +27% 01 Jul 2019 30 Sep 2019
Q2 2019 -69% +15% +17% 01 Apr 2019 30 Jun 2019
Q1 2019 -72% +34% +32% 01 Jan 2019 31 Mar 2019
Q4 2018 -75% +26% +26% 01 Oct 2018 31 Dec 2018
Q3 2018 -85% +11% +11% 01 Jul 2018 30 Sep 2018
Q2 2018 -84% +5.3% +6% 01 Apr 2018 30 Jun 2018
Q1 2018 -105% -15% -17% 01 Jan 2018 31 Mar 2018
Q4 2017 -101% -18% -22% 01 Oct 2017 31 Dec 2017
Q3 2017 -96% -40% -72% 01 Jul 2017 30 Sep 2017
Q2 2017 -89% -39% -79% 01 Apr 2017 30 Jun 2017
Q1 2017 -90% -37% -68% 01 Jan 2017 31 Mar 2017
Q4 2016 -83% -53% -176% 01 Oct 2016 31 Dec 2016
Q3 2016 -56% -49% -779% 01 Jul 2016 30 Sep 2016
Q2 2016 -50% -42% -512% 01 Apr 2016 30 Jun 2016
Q1 2016 -54% -62% -720% 01 Jan 2016 31 Mar 2016
Q4 2015 -30% -27% -936% 01 Oct 2015 31 Dec 2015
Q3 2015 -6.3% +11% +62% 01 Jul 2015 30 Sep 2015
Q2 2015 -8.1% 01 Apr 2015 30 Jun 2015
Q1 2015 8.7% 01 Jan 2015 31 Mar 2015
Q4 2014 -2.9% 01 Oct 2014 31 Dec 2014
Q3 2014 -17% 01 Jul 2014 30 Sep 2014

Eiger BioPharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -113% -46% -69% 01 Jan 2023 31 Dec 2023
2022 -67% -44% -194% 01 Jan 2022 31 Dec 2022
2021 -23% +32% +59% 01 Jan 2021 31 Dec 2021
2020 -55% +7.6% +12% 01 Jan 2020 31 Dec 2020
2019 -62% +13% +17% 01 Jan 2019 31 Dec 2019
2018 -75% +26% +26% 01 Jan 2018 31 Dec 2018
2017 -101% -18% -22% 01 Jan 2017 31 Dec 2017
2016 -83% -53% -176% 01 Jan 2016 31 Dec 2016
2015 -30% -27% -936% 01 Jan 2015 31 Dec 2015
2014 -2.9% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.